Covaxin Coming

Bharat Biotech and ICMR developed Covaxin, a vaccine for Coronavirus. The Drugs Controller General of India (DCGI) has given the drug approval for conduction of the third phase of clinical trials.
The study is estimated to cover a total of 28,500 participants with their ages varying from 18 or above. The study will be conducted across 10 states.
For more daily updates click here. Also for more related news updates click here.
News source: Zee News
Update by Ayesha Ayub
